REDHILL BIOPHARMA LTD's ticker is and the CUSIP is 757468903. A total of 1 filers reported holding REDHILL BIOPHARMA LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -100.0% | 18,000 | -69.9% | 0.00% | – |
| Q3 2022 | $30,000 | +2900.0% | 59,800 | +2747.6% | 0.00% | – |
| Q2 2022 | $1,000 | -93.8% | 2,100 | -68.2% | 0.00% | – |
| Q1 2022 | $16,000 | -66.7% | 6,600 | -64.9% | 0.00% | – |
| Q4 2021 | $48,000 | -79.2% | 18,800 | -42.0% | 0.00% | – |
| Q3 2021 | $231,000 | +4.1% | 32,400 | 0.0% | 0.00% | – |
| Q2 2021 | $222,000 | +16.2% | 32,400 | +12266.4% | 0.00% | – |
| Q1 2021 | $191,000 | – | 262 | +147.2% | 0.00% | – |
| Q4 2020 | $0 | – | 106 | -24.3% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 140 | +460.0% | 0.00% | – |
| Q2 2020 | $16,000 | +220.0% | 25 | +108.3% | 0.00% | – |
| Q1 2020 | $5,000 | -85.7% | 12 | -79.3% | 0.00% | – |
| Q4 2019 | $35,000 | -61.5% | 58 | -55.4% | 0.00% | – |
| Q3 2019 | $91,000 | +250.0% | 130 | +225.0% | 0.00% | – |
| Q2 2019 | $26,000 | -23.5% | 40 | -2.4% | 0.00% | – |
| Q1 2019 | $34,000 | +30.8% | 41 | -12.8% | 0.00% | – |
| Q4 2018 | $26,000 | +2500.0% | 47 | +2250.0% | 0.00% | – |
| Q3 2018 | $1,000 | -88.9% | 2 | -81.8% | 0.00% | – |
| Q2 2018 | $9,000 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |